>
Organization
Aspireo Pharmaceuticals Ltd.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed

News on Aspireo Pharmaceuticals Ltd.

... 7MM 15.1. Key Findings 15. Acromegaly: 7Major Market Analysis 14.6. Veldoreotide: Evotec/ Aspireo Pharmaceuticals 14.5. GT-02037: Pharmaspur 14.4. CAM2029: Novartis 14.3. ATL1103: Antisense Therapeutics 14.2. ...
... Apitope - ARCH Venture Partners - ArisGen - Asahi Kasei Pharma - Aspireo Pharmaceuticals - AstraZeneca - AZAD Pharma - Biodel - Biogen Idec - ...
... commercialization rights to Antisense Therapeutics' ATL1103 for endocrinology applications and to acquire Aspireo Pharmaceuticals' Somatoprim (DG3173), an investigational compound being studied for the treatment of ...
... The Göteborg, Sweden incorporated and Trevose, Pa.-based biotech is to buy Aspireo Pharmaceuticals Ltd.'s Somatoprim compound for the treatment of acromegaly. Separately it forged a ...
... treatments for acromegaly for a combined $35 million. Cortendo agreed to pay Aspireo Pharmaceuticals $30 million for somatoprim, or DG3173, a treatment designed to block ...
... in a private stock, a move that follows its recent deal with Aspireo Pharmaceuticals of Israel to acquire Somatoprim, an investigational compound being being studied ...
... diseases, today announced that it has entered into an agreement to acquire Aspireo Pharmaceuticals' Somatoprim (DG3173), an investigational compound being studied for the treatment of ...
  • be_ixf; php_sdk; php_sdk_1.4.15
  • https://relationshipscience.com/News/aspireo-pharmaceuticals-ltd-o73254078
  • https://relationshipscience.com/News/aspireo-pharmaceuticals-ltd-o73254078
Subscribe now for full coverage on Aspireo Pharmaceuticals Ltd.
Start My Free Trial